CVS Health's decision to withdraw Aetna's ACA plans by 2026 could leave nearly a million people in 17 states searching for ...

CVS Health's stock price received a positive prognosis from Truist Financial, boosting the target from $82 to $84. The ...

Big retailers’ ambitions to disrupt healthcare are falling apart. Companies have run into difficulties trying to make ...

Activist investor Glenview Capital is reducing its stake in healthcare giant CVS Health following its first-quarter earnings ...

CVS Health (CVS) stock in focus as Glenview Capital trims a third of its stake after the company's Q1 2025 earnings beat.

The summary highlights significant updates in the health sector, including Glenview Capital reducing its CVS stake, WeightWatchers' filing for bankruptcy, FDA's bargaining session cancellations, Novo ...

Activist investor Glenview Capital said on Tuesday it had reduced its holdings in CVS Health following the insurer's "healthy ...

Recent health news covers Glenview Capital's stake reduction in CVS Health, US FDA's new appointment of Vinay Prasad, and ...

Activist investor Glenview Capital said on Tuesday it reduced its holdings in CVS Health by 3.75 million shares after the ...

Activist investor Glenview Capital Management sold 3.75 million shares of CVS Health Corp. and pledged to keep the rest, ...

One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total return of 25% reflecting initial progress ...

Environmental groups on Monday slammed comments by the head of the U.S.-owned Tennessee Valley Authority suggesting the ...